From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 12,359,458 shares, representing 13.58% for $2,946.8 million under the buyback announced on December 9, 2021.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
210.6 USD | -1.19% | +2.15% | -7.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.35% | 17.97B | |
+19.28% | 84.52B | |
-26.95% | 72.21B | |
+4.65% | 27.74B | |
-0.46% | 17.46B | |
+4.69% | 15.82B | |
+8.14% | 13.55B | |
+6.59% | 13.31B | |
+70.00% | 12.5B | |
-1.22% | 12.42B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Tranche Update on Laboratory Corporation of America Holdings (NYSE: LH)'s Equity Buyback Plan announced on December 9, 2021.